AHRQ supports CER for complex patients
This article was originally published in The Gray Sheet
Agency for Healthcare Research and Quality seeks grant applications through Jan. 20, 2010, for research on the comparative effectiveness of using different strategies to prevent and manage chronic illness in patients with "specific constellations of co-morbid conditions." AHRQ plans to spend up to $6 million from its American Recovery and Reinvestment Act of 2009 funds for the grants. Objectives include prioritizing evidence-based tests and treatments for patients with multiple physical or mental co-morbidities and suggesting changes in timing and frequency in prevention and treatment guidelines. AHRQ also wants to clarify how co-existing chronic conditions impact the comparative value of certain treatment or prevention strategies. The agency also seeks evidence that could help refine chronic-disease quality measures for complex and frail patients
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.